日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Virological and drug-resistance outcomes for people living with HIV initiating or switching to tenofovir, lamivudine, and dolutegravir in six PEPFAR-supported countries: a prospective cohort study

在六个由美国总统艾滋病紧急救援计划(PEPFAR)支持的国家中,艾滋病毒感染者开始或改用替诺福韦、拉米夫定和多替拉韦治疗的病毒学和耐药性结果:一项前瞻性队列研究

Marc, Jean Bernard; McCarthy, Caitlyn; Wallis, Carole L; Kityo, Cissy; Hughes, Michael D; Godfrey, Catherine; Shah, N Sarita; Parikh, Urvi M; Maartens, Gary; Kanyike, Francis; Van Schalkwyk, Marije; Kihumuro, Raymond Bernard; Asiimwe, Philip; Tsikhutsu, Isaac; Munyanga, Cornelius; Some, Fatma F; Joseph, Yvetot; Flowers, Tracy; Mohapi, Lerato; Samaneka, Wadzanai P; Mponda, Kelvin; Rassool, Mohammed S; Pierre, Samuel; Woolley, Elizabeth; Manabe, Yukari C; Mellors, John W; Flexner, Charles; Koenig, Serena P; Mngqibisa, Rosie

Health-seeking behaviour and patient-related factors associated with the time to TB treatment initiation in four African countries: a cross-sectional survey

非洲四国结核病患者就医行为及相关因素与结核病治疗启动时间的关系:一项横断面调查

Sathar, Farzana; Charalambous, Salome; Velen, Kavindhran; Fielding, Katherine; Rachow, Andrea; Ivanova, Olena; Rassool, Mohammed S; Lalashowi, Julieth; Owolabi, Olumuyiwa; Nhassengo, Pedroso; Chihota, Violet; Evans, Denise

Southern African HIV Clinicians Society guidelines for antiretroviral therapy in adults: 2020 update

南部非洲艾滋病临床医师协会成人抗逆转录病毒治疗指南:2020 年更新版

Nel, Jeremy; Dlamini, Sipho; Meintjes, Graeme; Burton, Rosie; Black, John M; Davies, Natasha E C G; Hefer, Eric; Maartens, Gary; Mangena, Phetho M; Mathe, Moeketsi T; Moosa, Mahomed-Yunus; Mulaudzi, Muhangwi B; Moorhouse, Michelle; Nash, Jennifer; Nkonyane, Thandeka C; Preiser, Wolfgang; Rassool, Mohammed S; Stead, David; van der Plas, Helen; van Vuuren, Cloete; Venter, Willem D F; Woods, Joana F

Antiretroviral therapy in HIV-1-infected individuals with CD4 count below 100 cells/mm3 results in differential recovery of monocyte activation.

对于 CD4 计数低于 100 个细胞/mm3 的 HIV-1 感染者,抗逆转录病毒疗法会导致单核细胞活化的差异性恢复

Patro Sean C, Azzoni Livio, Joseph Jocelin, Fair Matthew G, Sierra-Madero Juan G, Rassool Mohammed S, Sanne Ian, Montaner Luis J

A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of a Chemokine Receptor 5 (CCR5) Antagonist to Decrease the Occurrence of Immune Reconstitution Inflammatory Syndrome in HIV-Infection: The CADIRIS Study

一项随机、双盲、安慰剂对照临床试验,旨在评估趋化因子受体5 (CCR5) 拮抗剂降低HIV感染者免疫重建炎症综合征发生率的疗效:CADIRIS研究

Sierra-Madero, Juan G; Ellenberg, Susan; Rassool, Mohammed S; Tierney, Ann; Belaunzarán-Zamudio, Pablo F; López-Martínez, Alondra; Piñeirúa-Menéndez, Alicia; Montaner, Luis J; Azzoni, Livio; Benítez, César Rivera; Sereti, Irini; Andrade-Villanueva, Jaime; Mosqueda-Gómez, Juan L; Rodriguez, Benigno; Sanne, Ian; Lederman, Michael M